RA Capital Management disposes of USD 254,920 of Werewolf Therapeutics common shares

Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.

HOWL

0.00
  • RA Capital Management, a 10% owner of Werewolf Therapeutics, reported selling 678,226 shares of common stock on June 9-11, 2026.
  • Sales were executed at weighted average prices of USD 0.37-0.38 per share.
  • Holdings fell to 5,076,685 shares for RA Capital Healthcare Fund, 361,229 shares for Nexus Fund II.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Werewolf Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000628), on June 11, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.